The weaker backdrop means the FTSE 100 index is forecast to give up all yesterday’s rise, with futures pointing to a decline ...

The news prompted a sell-off across the industry. In the US, shares in Pfizer and Moderna sank more than 5% in early trading, ...

GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

GSK fell 3.9% and AstraZeneca shed 3.1% ... Brent oil was quoted lower at USD72.08 a barrel late on Friday afternoon, down from USD72.43 at the time of the London equities close on Thursday. Gold was ...

As head of HHS, Kennedy would lead a sprawling federal department that encompasses more than 100 programs supporting medicine ...

London stocks had popped into the black by midday on Friday but gains were marginal as pharma shares took a hit and as data ...

London’s FTSE 100 struggled to maintain gains from earlier in the day and closed 7.58 points lower, or 0.09%, at 8,063.61.

Stocks in drug makers slumped after Donald Trump named vaccine sceptic Robert F Kennedy Jr as his health secretary.Shares in ...

Major companies like pharma giant GlaxoSmithKline (GSK) have established their largest AI teams in London. The city is a global leader in AI talent, as well as home to leading AI research centres, ...

UK pharma group posts ‘statistically significant’ trial results for treatment combined with Blenrep pulled in 2022 ...

An estimated 828 million adults (420 women, 408 men) had diabetes in 2022, an increase of 630 million since 1990. India (212 ...